LACTATE DEHYDROGENASE ACC. IFCC VER.2
Received Mar 21, 2025 · Event occurred Feb 28, 2025
Report 1823260-2025-00818 · MDR key 21662370
Device
Generic name
Lactate Dehydrogenase Test System
Manufacturer
Roche DiagnosticsCatalog number
08057958190
Lot number
837913
Product problems
- High Test Results
- Non Reproducible Results
- High Test Results
- Non Reproducible Results
Patient
NA · Unknown
- No Clinical Signs, Symptoms or Conditions
- No Clinical Signs, Symptoms or Conditions
Narrative
Additional Manufacturer Narrative
THE SERIAL NUMBER OF THE C 503 ANALYZER IS (B)(6). QUALITY CONTROL DATA SHOWED IMPRECISION. UPON REVIEW OF ALARM TRACE DATA, ABNORMAL ASPIRATION AND SAMPLE SHORT ALARMS WERE OBSERVED. THESE ARE INDICATORS OF POSSIBLE POOR SAMPLE QUALITY. THE CUSTOMER REPLACED THE SAMPLE PROBE. THE INVESTIGATION IS ONGOING.
Description of Event or Problem
THE INITIAL REPORTER STATED THEY RECEIVED DISCREPANT RESULTS FOR ONE PATIENT SAMPLE TESTED WITH LACTATE DEHYDROGENASE ACC. IFCC VER.2 ON A COBAS C 503 ANALYTICAL UNIT. A LITHIUM HEPARIN TUBE OF THE SAMPLE RESULTED IN AN LDH VALUE OF 270 U/L. A SECOND LITHIUM HEPARIN TUBE COLLECTED FROM THE PATIENT AT THE SAME TIME RESULTED IN AN LDH VALUE OF 608 U/L.
Additional Manufacturer Narrative
CALIBRATION DATA WAS ACCEPTABLE. THE SAMPLE CENTRIFUGATION WAS NOT PERFORMED AS RECOMMENDED BY THE TUBE MANUFACTURER. LITHIUM HEPARIN PLASMA TUBES WERE USED BY THE CUSTOMER. PER PRODUCT LABELING: "CAUTION: PLASMA FROM PRIMARY TUBES HANDLED ACCORDING TO THE MANUFACTURER'S INSTRUCTIONS CAN STILL CONTAIN CELLS, LEADING TO IMPLAUSIBLY HIGH RESULTS. ALTERNATIVELY, IT IS RECOMMENDED TO TRANSFER THE PLASMA FROM THE PRIMARY TUBE TO A SECONDARY SAMPLE TUBE.". THE INVESTIGATION DETERMINED THE ISSUE IS CONSISTENT WITH INSUFFICIENT PRE-ANALYTIC SAMPLE HANDLING.